CCL5 is a well‐known chemotaxis‐mediating factor in immune regulatory processes and is known to be released from AML cells in a subset of patients (Bruserud et al., 2007; Reikvam et al., 2019). The gene discussed is CCL5; the disease is acute myeloid leukemia.